Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biopharmx Corp (BPMX)

Biopharmx Corp (BPMX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,322
  • Shares Outstanding, K 18,278
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,690 K
  • 60-Month Beta 0.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/09/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +262,994.74%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +82.14%
on 05/01/20
0.8700 -41.38%
on 05/14/20
+0.2150 (+72.88%)
since 04/17/20
3-Month
0.2500 +104.00%
on 03/17/20
0.8700 -41.38%
on 05/14/20
+0.1200 (+30.77%)
since 02/18/20
52-Week
0.2500 +104.00%
on 03/17/20
1.1800 -56.78%
on 06/25/19
-0.5300 (-50.96%)
since 05/17/19

Most Recent Stories

More News
Timber Pharmaceuticals Announces Investor Conference Call

Call to be held on Tuesday, May 26 at 11:00am EDT

BPMX : 0.5100 (-9.49%)
BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020

, /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced...

BPMX : 0.5100 (-9.49%)
BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting

, /PRNewswire/ --  (NYSE American: BPMX) today announced that all proposals related to its proposed merger with Timber Pharmaceuticals LLC ("Timber") were approved by BioPharmX's stockholders at a special...

BPMX : 0.5100 (-9.49%)
BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals

CAMPBELL, Calif., /PRNewswire/ -- (NYSE American: BPMX) is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and related matters as described...

BPMX : 0.5100 (-9.49%)
BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that the date of its special stockholders' meeting to consider and vote on the proposed merger of BioPharmX with Timber Pharmaceuticals...

BPMX : 0.5100 (-9.49%)
Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials Grant

Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced the company...

BPMX : 0.5100 (-9.49%)
BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received notification on March 24, 2020 from...

BPMX : 0.5100 (-9.49%)
BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement

BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments...

BPMX : 0.5100 (-9.49%)
BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended...

BPMX : 0.5100 (-9.49%)
BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American

BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received a notice on September 19, 2019 from...

BPMX : 0.5100 (-9.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BPMX with:

Business Summary

BioPharmX Corporation is a specialty pharmaceutical company. The company focuses on the development of novel drug delivery products for women's health, dermatology and otolaryngology markets. The Company's product pipeline includes products in categories consists of prescription products, over-the-counter...

See More

Key Turning Points

2nd Resistance Point 0.5661
1st Resistance Point 0.5381
Last Price 0.5100
1st Support Level 0.4689
2nd Support Level 0.4277

See More

52-Week High 1.1800
Fibonacci 61.8% 0.8247
Fibonacci 50% 0.7150
Fibonacci 38.2% 0.6053
Last Price 0.5100
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar